Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Voyager Therapeutics
AddedFeb 21, 2024
UpdatedJun 18, 2026
Voyager Therapeutics

Voyager Therapeutics

Public

Cambridge-based Voyager Therapeutics, Inc. is a clinical-stage gene therapy company developing treatments for severe CNS diseases.

HQ
Cambridge, MA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded in Cambridge, Massachusetts, Voyager Therapeutics, Inc. is a clinical-stage gene therapy company dedicated to developing life-changing treatments for severe central nervous system (CNS) diseases. The company's core mission is to leverage the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Voyager Therapeutics focuses on creating transformative gene therapies aimed at treating fatal and debilitating CNS conditions.

Voyager Therapeutics has garnered attention through its affiliations with notable scientists and investors in the biotechnology sector. The company is publicly traded on Nasdaq under the ticker symbol VYGR. Key achievements include dosing participants in clinical trials and presenting at multiple investor conferences, showcasing their progress and potential impact. Voyager Therapeutics' innovative approach has positioned it as a significant player in the quest to develop effective treatments for severe neurological diseases.

Voyager Therapeutics - Similar Companies

Poseida Therapeutics logo

Poseida Therapeutics

poseida.com

Kriya Therapeutics logo

Kriya Therapeutics

Neurogene logo

Neurogene

neurogene.com

Intellia Therapeutics logo

Intellia Therapeutics

intelliatx.com

Lacerta Therapeutics logo

Lacerta Therapeutics

Taysha Gene Therapies logo

Taysha Gene Therapies

tayshagtx.com

Lysosomal Therapeutics logo

Lysosomal Therapeutics

lysosomaltx.com

VistaGen Therapeutics logo

VistaGen Therapeutics

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Intergalactic Therapeutics logo

Intergalactic Therapeutics

Triplet Therapeutics logo

Triplet Therapeutics

triplettx.com

Ovid Therapeutics logo

Ovid Therapeutics

ovidrx.com

bluebird bio logo

bluebird bio

bluebirdbio.com

Denali Therapeutics logo

Denali Therapeutics

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Voyager Therapeutics - Quick Facts

Who are Voyager Therapeutics' competitors?

Companies similar to Voyager Therapeutics include Poseida Therapeutics, Kriya Therapeutics, Neurogene and Intellia Therapeutics.

When was Voyager Therapeutics founded?

Voyager Therapeutics was founded in 2014.

Where is Voyager Therapeutics' headquarters located?

Voyager Therapeutics' headquarters is located in Cambridge, MA, US.

When was Voyager Therapeutics' last funding round?

Voyager Therapeutics' most recent funding round was for $100M (USD) in January 2024.

How much has Voyager Therapeutics raised to-date?

As of Jan 4, 2024, Voyager Therapeutics has raised a total of $374M (USD).

How many employees does Voyager Therapeutics have?

Voyager Therapeutics has 125 employees as of Feb 6, 2024.

Voyager Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Gene Therapy
Tags
  • Biotech
Unique IDs
  • ein: 000000000
  • secCik: 0001640266
  • ticker: VYGR
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research